EXTON, Pa., Feb. 27, 2013 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading global developer and manufacturer of components and systems for injectable drug delivery, announces ...
Novel needle-free Intradermal (ID) delivery technologies provide effective alternatives to traditional Mantoux ID administration using needles. An in-depth review of 59 published scientific ...
GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company that has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced they received an ...
In Cuba, the routine immunization (RI) schedule for polio consists of two doses of fIPV administered at 4 and 8 months of age administered intradermally with N/S. However, ID administration with N/S ...
The global intradermal injection market size is expected to surpass an impressive valuation of US$ 3,878 Million in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 10.8% from ...
The global Intradermal Injection Market is expected to exceed an impressive valuation of US$ 3,878 Million in 2022, with a compound annual growth rate (CAGR) of 10.8% projected from 2022 to 2032.
Tokyo, Japan, April 10, 2015 – Daiichi Sankyo Co., Ltd. (hereafter, Daiichi Sankyo) and Terumo Corporation (hereafter, Terumo) today announced that Japan Vaccine Co., Ltd. (hereafter, Japan Vaccine), ...
The adapter is designed to help improve the consistency and reliability of intradermal injections for vaccines and other injectable drugs. The system will complement West's portfolio of prefilled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results